Cancer of unknown origin in gynaecologic oncology

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00843989%3A_____%2F23%3AE0110298" target="_blank" >RIV/00843989:_____/23:E0110298 - isvavai.cz</a>
Result on the web
<a href="https://oss.ejgo.net/files/article/20230615-39/pdf/EJGO2022111301.pdf" target="_blank" >https://oss.ejgo.net/files/article/20230615-39/pdf/EJGO2022111301.pdf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.22514/ejgo.2023.045" target="_blank" >10.22514/ejgo.2023.045</a>

Result language
angličtina
Original language name
Cancer of unknown origin in gynaecologic oncology
Original language description
Tumour of unknown primary (primum ignotum) is a metastatic disease that generally shows a poor response to treatment and prognosis. Although it exhibits a trend of decreasing incidence, the diagnostic processes are complicated. The available literature shows that 5–30% of metastases involve the ovary, but it remains unclear how often ovarian infiltration is found in tumours of unknown primary. The most common metastatic disease that affects the ovaries are malignant tumours of the gastrointestinal tract, breast, pancreas, and haematological malignancies. Usually, the first step to distinguish between a primary and a secondary tumour of the ovary is an ultrasound examination, where the ovarian metastases have some characteristic features. Here we report our experience with primum ignotum in a patient with simultaneous ovarian and bone marrow involvement.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30214 - Obstetrics and gynaecology

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)